Your browser doesn't support javascript.
loading
Record Setting Temperatures in the Setting of SARS-CoV-2 Suggests Dexmedetomidine Drug-Induced Fever: A Case Report.
Meier, Megan; Linn, Becky S.
Affiliation
  • Meier M; Veterans Affairs Eastern Colorado Healthcare System, Aurora, USA.
  • Linn BS; University of Wyoming, Laramie, USA.
J Investig Med High Impact Case Rep ; 12: 23247096241260959, 2024.
Article in En | MEDLINE | ID: mdl-38869108
ABSTRACT
Patients infected with COVID-19 can develop coinfections or acute respiratory disorder that result in ventilation. Dexmedetomidine is a common medication used to sedate ventilated patients in the intensive care unit and for nonintubated patients prior to a surgical procedure. As a highly selective alpha-2 agonist, dexmedetomidine provides sedation while reducing the need for anxiolytics or opioids. However, previous case reports suggest dexmedetomidine can induce fever in a variety of conditions. The purpose of this case report is to describe a patient who acquired a fever of 42.6°C in the setting of COVID-19 after administration of dexmedetomidine.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dexmedetomidine / Fever / SARS-CoV-2 / COVID-19 / Hypnotics and Sedatives Limits: Humans / Male / Middle aged Language: En Journal: J Investig Med High Impact Case Rep Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dexmedetomidine / Fever / SARS-CoV-2 / COVID-19 / Hypnotics and Sedatives Limits: Humans / Male / Middle aged Language: En Journal: J Investig Med High Impact Case Rep Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos